3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Terminated
3
Completed
3
Unknown
2
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Genitourinary
1
Breast
1
Conditions
Carcinoma, Non-Small-Cell Lung
381
Breast Neoplasms
364
Colorectal Neoplasms
238
Stomach Neoplasms
218
Carcinoma, Hepatocellular
155
Lung Neoplasms
123
Neoplasms
120
Pancreatic Neoplasms
109
Prostatic Neoplasms
100
Neoplasm Metastasis
96
Recurrence
95
Rectal Neoplasms
95
Ovarian Neoplasms
90
Nasopharyngeal Carcinoma
88
Esophageal Neoplasms
82
Esophageal Squamous Cell Carcinoma
81
Lymphoma, Large B-Cell, Diffuse
79
Melanoma
75
Small Cell Lung Carcinoma
71
Uterine Cervical Neoplasms
70
Lymphoma
70
Leukemia, Myeloid, Acute
70
Brain Neoplasms
69
Sarcoma
68
Head and Neck Neoplasms
68
Squamous Cell Carcinoma of Head and Neck
67
Multiple Myeloma
65
Carcinoma, Renal Cell
63
Triple Negative Breast Neoplasms
61
Lymphoma, Non-Hodgkin
53
Interventions
exemestane
1
cabazitaxel
1
bicalutamide
1
Letrozole
1
Histamine H2 Antagonists
1
Histamine Antagonists
1
Aromatase Inhibitors
1
Antiemetics
1
Anastrozole
1
Adrenal Cortex Hormones
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2
×
Unknown
×
Bulbo-Spinal Atrophy, X-Linked
×
Clear all
NCT03050866
2021-08-20
CABA-V7
Erasmus Medical Center
Phase 2
Unknown
140 enrolled
NCT02910050
2017-12-22
BETTER
Sun Yat-sen University
Phase 2
Unknown
58 enrolled